EUVIMEDEUVIMED entdecken
Crossref

Preliminary Evaluation of Synthetic Amanitin Analogs as Novel Payloads for Potent Antibody−Drug Conjugates

Tuấn Trung Nguyễn iD, Juliette Froelich, Kayla C Newell, Mihajlo Todorovic, David M Perrin iD

Molecular Pharmaceutics · 02.11.2026 · 23 (11) · 5585-5595

DOI: 10.1021/acs.molpharmaceut.6c00708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 04.10.2026. Verfasst von Tuấn Trung Nguyễn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, University of British Columbia, 2036 Main Mall, V6T-1Z1, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Immunoconjugates, Amanitins, Alpha-Amanitin. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Canadian Institutes of Health Research (CIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha-amanitinthe principal toxin of Amanita phalloides, infamous for its hepatotoxicity and lethalityhas been receiving considerable attention as a candidate payload in antibody−drug conjugates (ADCs). Previously, we identified three synthetic amatoxins with heightened cytotoxicity against CHO, HEK 293, and HeLa cells. In this work, these analogs were advanced as ADC payloads using the well-established anti-HER2 antibody trastuzumab to provide a head-to-head comparative study against α-amanitin, where all payloads (synthetic or natural) are linked via a glutaric linker; esterification to the dihydroxy-isoleucine on the toxin and via an amide to an antibody lysine. Tested as ADC payloads, one synthetic amatoxin outperformed the natural toxin across various drug−antibody ratios (DARs) and across a panel of HER2-overexpressing cell lines; against SK-BR-3 cells, this ADC shows a 25-fold greater potency at DAR 2.1 compared to the same ADC linked to α-amanitin at DAR 2.0. At DAR values of 5−6, this toxin confers low-femtomolar IC50 values on the corresponding trastuzumab conjugate when assayed against SK-BR-3 cells and shows exalted cytotoxicity against a panel of HER2-overexpressing cell lines compared to the ADC linked to α-amanitin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesAmanitinsAlpha-AmanitinHumansTrastuzumabAnimalsCell Line, TumorHEK293 CellsCHO CellsHeLa CellsErb-b2 Receptor Tyrosine KinasesCricetulus

Stichwörter der Autor:innen

ADCDARHER2-overexpressingSK-BR-3amanitinamatoxinantibodycytotoxicitypayloads

Substanzen

ImmunoconjugatesTrastuzumabAmanitinsErb-b2 Receptor Tyrosine KinasesERBB2 protein, humanAlpha-Amanitin

Autor:innen und Institutionen

  • Chemistry Department, University of British Columbia, 2036 Main Mall, V6T-1Z1, Vancouver, British Columbia, Canada.

ORCID-Profile: Tuấn Trung Nguyễn, David M Perrin

Förderung

  • Canadian Institutes of Health Research (CIHR)

Zitieren

APA

Nguyễn, T. T., Froelich, J., Newell, K. C., Todorovic, M., & Perrin, D. M. (2026). Preliminary Evaluation of Synthetic Amanitin Analogs as Novel Payloads for Potent Antibody−Drug Conjugates. Molecular Pharmaceutics, 23(11), 5585-5595. https://doi.org/10.1021/acs.molpharmaceut.6c00708

Vancouver

Nguyễn TT, Froelich J, Newell KC, Todorovic M, Perrin DM. Preliminary Evaluation of Synthetic Amanitin Analogs as Novel Payloads for Potent Antibody−Drug Conjugates. Molecular Pharmaceutics. 2026;23(11):5585-5595. doi:10.1021/acs.molpharmaceut.6c00708

BibTeX
@article{Nguyn2026,
  author = {Nguyễn, Tuấn Trung and Froelich, Juliette and Newell, Kayla C and Todorovic, Mihajlo and Perrin, David M},
  title = {Preliminary Evaluation of Synthetic Amanitin Analogs as Novel Payloads for Potent Antibody−Drug Conjugates},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {11},
  pages = {5585--5595},
  doi = {10.1021/acs.molpharmaceut.6c00708}
}
Kostenlos starten →